Your browser doesn't support javascript.
loading
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.
Mondi, Annalisa; Cimini, Eleonora; Colavita, Francesca; Cicalini, Stefania; Pinnetti, Carmela; Matusali, Giulia; Casetti, Rita; Maeurer, Markus; Vergori, Alessandra; Mazzotta, Valentina; Gagliardini, Roberta; De Zottis, Federico; Schininà, Vincenzo; Girardi, Enrico; Puro, Vincenzo; Ippolito, Giuseppe; Vaia, Francesco; Capobianchi, Maria Rosaria; Castilletti, Concetta; Agrati, Chiara; Antinori, Andrea.
  • Mondi A; HIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Cimini E; Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Colavita F; Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Cicalini S; HIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Pinnetti C; HIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Matusali G; Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Casetti R; Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Maeurer M; Immunotherapy Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal.
  • Vergori A; I Medical Clinical, University of Mainz, Mainz, Germany.
  • Mazzotta V; HIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Gagliardini R; HIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • De Zottis F; HIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Schininà V; HIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Girardi E; Radiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Puro V; Clinical Epidemiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
  • Ippolito G; AIDS Reference Centre-National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Vaia F; Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
  • Capobianchi MR; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
  • Castilletti C; Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Agrati C; Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Antinori A; Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
J Med Virol ; 93(3): 1796-1804, 2021 03.
Article en En | MEDLINE | ID: mdl-32975842

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Antirretrovirales / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Antirretrovirales / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article